From an industrial perspective, waivers reduce the time and cost associated with the development and regulatory approval of new products. By eliminating unnecessary testing, companies can allocate resources more efficiently towards innovation and development. Additionally, waivers promote the adoption of the 3Rs (Replacement, Reduction, and Refinement) in animal testing, which is increasingly important for companies committed to corporate social responsibility.
